Sign inJoin waitlistJoin the waitlist

Kent Robertson

Associate Director, Pediatric Stem Cell Transplantation · Indiana University School of Medicine

Credentials: · · ·

History

Indiana University School of Medicine
Present

Research

Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha)
Molecular and Cellular Biology · 1990 · 350 citations
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow
Cell · 2008 · 277 citations
Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation
Blood · 2000 · 184 citations

Franklin Smith
6 papers
Robert Hromas
6 papers
Brigitte Widemann
4 papers
Jaishri Blakeley
4 papers
PH
Paul Haut
4 papers
Scott Plotkin
4 papers
W Goebel
4 papers
Bruce Korf
3 papers
David Ingram
3 papers
Gail Vance
3 papers
GN
Grzegorz Nalepa
3 papers
Kenneth Cornetta
3 papers

Grants

Phase 2 Study of Imatinib for the Treatment of Airway Tumors in Children with Neurofibromatosis Type 1
Food and Drug Administration · R01
Contact PI · $400K · Indiana University Indianapolis
2015–2020
Indiana University Center for Pediatric Pharmacology
National Institute of Child Health and Human Development · U54
Project lead · $645.6K · Indiana University Indianapolis
2017
Ape Expression/Leukemia Response to Chemo/Radiotherapy
National Cancer Institute · R01
Contact PI · $1M · Indiana University Indianapolis
1998–2003
Retinoic Acid Receptors in Neuroblastoma Differentiation
National Institute of Neurological Disorders and Stroke · R29
Contact PI · $524.8K · Indiana University Indianapolis
1994–2000

Clinical trials

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
Principal investigator · Completed · Phase 1, Phase 2
Kent Robertson
2012–2016